Stockreport

Acorda Therapeutics Implements Corporate Restructuring, Provides Third Quarter 2019 Update

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF Total non-GAAP operating expenses for the full year 2020 expected to be $180 - $190 million1Estimated 2020 operating expenses reduced by ~$60 million compared to 2019 re [Read more]